Literature DB >> 25240585

A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma.

Qiliang Xi1, Ning Gao2, Xuejin Zhang1, Bo Zhang1, Weiyuan Ye1, Jun Wu1, Xuejun Zhang3.   

Abstract

In recent years, widespread antisense transcripts have been identified systematically in mammalian cells and are known to regulate gene expression, although their functional significance remains largely unknown. Previous work has identified that acetylcholinesterase (AChE) is expressed aberrantly in various malignant tumors and function as a tumor growth suppressor. However, the mechanism of AChE gene regulation in tumors remains unclear. In this study, we show that the AChE antisense RNA (AChE-AS) play an important role in AChE expression regulation. An inverse relationship was identified between AChE-AS and AChE expression in hepatocellular carcinoma and hepatoma cells. The silenced AChE-AS corresponds to elevated expression of AChE. Furthermore, we demonstrated that reduced AChE-AS increased H3K4 methylation and decreased H3K9 methylation in the AChE promoter region. As expected, elevated AChE levels induced by inhibition of AChE-AS enhanced anticarcinogen-induced apoptosis. These observations demonstrated that AChE-AS modulates AChE expression and exerts an anti-apoptotic effect through direct repression of AChE expression in HCC cells. Thus, natural antisense RNA may play an important role in AChE regulation via affecting the epigenetic modification in the AChE promoter region.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AChE antisense RNA; Acetylcholinesterase; Apoptosis; Cis-platin; Epigenetic modulation; Mitomycin C

Mesh:

Substances:

Year:  2014        PMID: 25240585     DOI: 10.1016/j.biocel.2014.09.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

Review 1.  Role of acetylcholinesterase in lung cancer.

Authors:  Hui-Jun Xi; Ren-Pei Wu; Jing-Jing Liu; Ling-Juan Zhang; Zhao-Shen Li
Journal:  Thorac Cancer       Date:  2015-03-20       Impact factor: 3.500

2.  Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression.

Authors:  B Huang; J H Song; Y Cheng; J M Abraham; S Ibrahim; Z Sun; X Ke; S J Meltzer
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

3.  Antisense transcription licenses nascent transcripts to mediate transcriptional gene silencing.

Authors:  Yunkun Dang; Jiasen Cheng; Xianyun Sun; Zhipeng Zhou; Yi Liu
Journal:  Genes Dev       Date:  2016-11-17       Impact factor: 11.361

4.  Changes in Cholinesterase Activity in Blood of Adolescent with Metabolic Syndrome after Supplementation with Extract from Aronia melanocarpa.

Authors:  Piotr Duchnowicz; Anna Ziobro; Elżbieta Rapacka; Maria Koter-Michalak; Bożena Bukowska
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

Review 5.  Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia.

Authors:  Alexander A Wurm; Cristina Pina
Journal:  Front Oncol       Date:  2019-09-11       Impact factor: 6.244

6.  Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.

Authors:  Baoshan Wang; Lei Zhao; Weiwei Chi; Huan Cao; Weina Cui; Wenxia Meng
Journal:  Epigenetics Chromatin       Date:  2019-06-13       Impact factor: 4.954

Review 7.  Characteristics of Antisense Transcript Promoters and the Regulation of Their Activity.

Authors:  Shudai Lin; Li Zhang; Wen Luo; Xiquan Zhang
Journal:  Int J Mol Sci       Date:  2015-12-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.